XML 50 R54.htm IDEA: XBRL DOCUMENT v3.19.3
Related Party Transactions (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Nov. 30, 2016
Mar. 31, 2016
Jan. 31, 2016
May 31, 2015
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Dec. 31, 2013
Dec. 31, 2010
Dec. 31, 2018
Related-Party Transactions (Textual) [Abstract]                      
Long-term other assets         $ 2,731,055   $ 2,731,055       $ 2,669,998
GeneOne Life Sciences                      
Related-Party Transactions (Textual) [Abstract]                      
Investment owned (in shares)         1,644,155   1,644,155        
Payment received for license granted                   $ 3,000,000  
Term                 20 years    
Milestone-based ownership target     35.00% 35.00%              
Revenue from related parties         $ 31,000 $ 155,000 $ 94,000 $ 305,000      
Operating expenses related to affiliated entity         232,000 1,900,000 2,100,000 4,700,000      
Accounts receivable         128,000   128,000       0
Accounts payable and accrued liability         107,000   107,000       372,000
Long-term other assets         338,000   338,000       381,000
Director                      
Related-Party Transactions (Textual) [Abstract]                      
Term   5 years                  
Revenue from related parties           952,000   3,200,000      
Operating expenses related to affiliated entity         313,000 615,000 1,100,000 1,400,000      
Accounts receivable         287,000   287,000       258,000
Expenses to reimburse   $ 3,100,000                  
Awarded amount $ 6,100,000                    
Contra-research and development expense         482,000   1,700,000        
Accounts payable/accrued liabilities         355,000   355,000       554,000
Deferred Grant Funding, From Affiliate         856,000   856,000        
Plumbline Life Sciences                      
Related-Party Transactions (Textual) [Abstract]                      
Revenue from related parties         22,000 $ 30,000 86,000 $ 88,000      
Accounts receivable         $ 564,000   $ 564,000       $ 478,000
Plumbline Life Sciences | Available-for-sale Securities                      
Related-Party Transactions (Textual) [Abstract]                      
Investment owned (in shares)         395,758   395,758